Table 1 Characteristics of 73,672 VA patients prescribed direct-acting oral anticoagulants between 2011 and 2016
Characteristic | Percentage |
|---|---|
Age (yrs) | |
 < 65 | 16% |
 65–74 | 44% |
 75–84 | 27% |
 > 85 | 13% |
Sex | Â |
 Female | 2% |
 Male | 98% |
Race | |
 White | 86% |
 Black | 8% |
 Other | 6% |
Geographic Region | |
 Northeast | 14% |
 Mid-West | 24% |
 West (Incl. Pacific) | 22% |
 South | 40% |
Body Mass Index (kg/m2) | |
 < 25 | 19% |
 25–29.9 | 33% |
 30–34.9 | 26% |
 > = 35 | 28% |
Comorbid Conditions | |
 Heart Failure | 15% |
 Hypertension | 73% |
 Vascular Disease | 17% |
 Diabetes | 48% |
 Prior Bleeding | 4% |
 Prior Stroke | 7% |
CHA2DS2-VASc Score (%) | |
 0–1 | 11% |
 2–4 | 77% |
 5–9 | 13% |
eGFR Categories (%), in units of mL/min/1.73 m2 | |
 < 30 | 2% |
 30–44 | 9% |
 45–59 | 15% |
 > 60 | 74% |
Elixhauser Comorbidities | |
 0–2 | 30% |
 3–4 | 41% |
 > = 5 | 29% |